Wegovy vs Zepbound: Comparing the Newest Weight Loss Medications

•7 min read
Conceptual image highlighting choice between health foods and sweets, symbolized by broccoli and lollipops.

Photo by Nataliya Vaitkevich via Pexels

Curious about the two newest heavy-hitters in weight loss medication? You're not alone. Wegovy and Zepbound have both made headlines for their impressive results, but understanding the differences between these medications can feel like comparing apples to... well, slightly different apples. Let's break down everything you need to know about Wegovy vs Zepbound to help you have an informed conversation with your healthcare provider.

The Science Behind the Medications

Both Wegovy and Zepbound belong to a revolutionary class of medications called GLP-1 receptor agonists. Think of them as master regulators that help control your appetite and blood sugar - like having a wise friend who gently reminds you when you've had enough to eat.

Active Ingredients

  • Wegovy (semaglutide): A once-weekly injection that mimics the natural GLP-1 hormone[1]
  • Zepbound (tirzepatide): A dual-action medication that works on both GLP-1 and GIP receptors[2]
Middle-aged man using an inhaler to manage respiratory issues indoors.

Photo by Cnordic Nordic via Pexels

Dosing: How They Stack Up

Starting these medications is like learning to swim - you begin in the shallow end and gradually work your way deeper. Both medications follow a step-up approach to minimize side effects.

Wegovy Dosing Schedule:

  • Month 1: 0.25mg weekly
  • Month 2: 0.5mg weekly
  • Month 3: 1.0mg weekly
  • Month 4: 1.7mg weekly
  • Maintenance: 2.4mg weekly

Zepbound Dosing Schedule:

  • Month 1: 2.5mg weekly
  • Month 2: 5.0mg weekly
  • Month 3: 7.5mg weekly
  • Month 4: 10mg weekly
  • Optional: Up to 15mg weekly

Weight Loss Results: By the Numbers

Ready for some impressive statistics? In clinical trials, both medications showed remarkable results, but with some notable differences.

Wegovy Results

  • Average weight loss: 15% after 68 weeks[3]
  • For a 200-pound person, that's about 30 pounds
  • Nearly 1 in 3 people lost 20% or more of their body weight

Zepbound Results

  • Average weight loss: 20.9% at highest dose after 72 weeks[4]
  • For a 200-pound person, that's about 42 pounds
  • Over 40% of participants lost 20% or more of their body weight

Side Effects and Safety

Both medications have similar side effect profiles - think of them as distant cousins who share some family traits.

Common side effects for both include:

  • Nausea (usually temporary)
  • Digestive issues
  • Constipation or diarrhea
  • Fatigue

Cost and Coverage Considerations

Here's where things get interesting - and potentially expensive. Insurance coverage varies widely:

Wegovy

  • List price: ~$1,349 per month
  • More likely to be covered by insurance
  • Many insurance plans require prior authorization

Zepbound

  • List price: ~$1,059 per month
  • Newer to market, coverage still expanding
  • Manufacturer offering initial savings programs

Sources and References

[1] Davies M, et al. "Once-Weekly Semaglutide in Adults with Overweight or Obesity." N Engl J Med. 2021;384(11):989-1002.

[2] Jastreboff AM, et al. "Tirzepatide Once Weekly for the Treatment of Obesity." N Engl J Med. 2022;387(3):205-216.

[3] Wilding JPH, et al. "Once-Weekly Semaglutide in Adults with Overweight or Obesity." N Engl J Med. 2021;384:989-1002.

[4] Jastreboff AM, et al. "SURMOUNT-1 Study Group. Tirzepatide Once Weekly for the Treatment of Obesity." N Engl J Med. 2022;387:205-216.

Medical Disclaimer

This article is for informational purposes only and does not constitute medical advice. Always consult with a qualified healthcare provider about your specific situation before starting or changing any medication. Individual results may vary, and medication responses can differ from person to person.